Holen Sie sich die Stockscreener-App
61.86
0.03%
0.02
Handel nachbörslich:
61.86
Finanzdaten der Cg Oncology Inc-Aktie (CGON)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
6.83%
1.157
|
1.083 | 2.322 | 1.666 | - |
| Research and Development |
24.99%
54.66
|
43.73 | - | - | - |
| Operating Income/Loss |
30.14%
-86.40
|
-66.39 | -48.70 | -51.13 | -48.74 |
| Nonoperating Income/Loss |
18.72%
7.345
|
6.187 | 7.391 | 7.321 | 7.315 |
| Net Income/Loss |
31.32%
-79.06
|
-60.20 | -41.31 | -43.81 | -41.43 |
| Basic Average Shares |
4.36%
88.20
|
84.52 | 0.9201 | 76.73 | 76.23 |
| Diluted Average Shares |
4.36%
88.20
|
84.52 | 0.9201 | 76.73 | 76.23 |
| Basic Earnings Per Share |
26.76%
-0.90
|
-0.71 | -0.51 | -0.57 | -0.54 |
| Diluted Earnings Per Share |
26.76%
-0.90
|
-0.71 | -0.51 | -0.57 | -0.54 |
8.67%
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):